Dr. Ranganath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8111 S Emerson Ave
Ste 101
Indianapolis, IN 46237Phone+1 317-859-5252Fax+1 317-859-5258
Education & Training
- University of Tennessee Medical Center at KnoxvilleResidency, Internal Medicine, 2012 - 2015
- Indiana University School of MedicineClass of 2012
- Scripps Mercy HospitalChief Residency, Internal Medicine
- University of TennesseeFellowship, Hematology and Medical Oncology
Certifications & Licensure
- CA State Medical License 2015 - 2025
- IN State Medical License 2019 - 2025
- TN State Medical License 2013 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 78 citationsAdministration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma.Harsha Ranganath, Timothy J Panella
Journal of Immunotherapy. 2015-05-26 - 1 citationsUnusual recurrent metastasizing benign breast papilloma: a case reportAmit L Jain, Janice Nhan Mullins, Justin R. Smith, Poojitha Valasareddy, Emily Miller
Journal of Medical Case Reports. 2020-02-19 - 7 citationsAssociation of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.Harsha Ranganath, Amit L Jain, Justin R Smith, Julie Ryder, Amina Chaudry
BMC Cancer. 2022-04-14
Press Mentions
- OncLive® Presents Its Latest State of the Science Summit™ on Genitourinary CancersNovember 20th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: